<html>
<head>PUBMED IDs for OPA3</head>
<body bgcolor='#C5F0F2'><h1>OPA3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/11668429/'>Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews.</a> October 23  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12126933/'>3-Methylglutaconic aciduria type III in a non-Iraqi-Jewish kindred: clinical and molecular findings.</a> July 20  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/15040889/'>Expression of MRP14 gene is frequently down-regulated in Chinese human esophageal cancer.</a> March 26  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15342707/'>OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract.</a> September 3  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15902555/'>OPA3 mutation screening in patients with unexplained 3-methylglutaconic aciduria.</a> May 20  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15924081/'>[An OPA3 gene mutation is responsible for the disease associating optic atrophy and cataract with extrapyramidal signs].</a> June 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16158427/'>Optic atrophy and sensorineural hearing loss in a family caused by an R445H OPA1 mutation.</a> September 15  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16527507/'>Association of 3-methylglutaconic aciduria with sensori-neural deafness, encephalopathy, and Leigh-like syndrome (MEGDEL association) in four patients with a disorder of the oxidative phosphorylation.</a> March 11  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16648378/'>Autosomal dominant optic atrophy associated with hearing impairment and impaired glucose regulation caused by a missense mutation in the WFS1 gene.</a> May 2  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16648377/'>Mutations responsible for Larsen syndrome cluster in the FLNB protein.</a> May 2  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16648376/'>Oculopharyngeal muscular dystrophy: a point mutation which mimics the effect of the PABPN1 gene triplet repeat expansion mutation.</a> May 2  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16838891/'>[Costeff syndrome: a syndrome that was described in Israel and the responsible gene discovered by an Israeli doctor].</a> July 15  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18222992/'>A missense mutation in the murine Opa3 gene models human Costeff syndrome.</a> January 29  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18496845/'>Hereditary optic neuropathies share a common mitochondrial coupling defect.</a> May 23  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18985435/'>Costeff optic atrophy syndrome: new clinical case and novel molecular findings.</a> November 6  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19268652/'>Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders.</a> July 29  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19319978/'>Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations.</a> September 24  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20350831/'>OPA3, mutated in 3-methylglutaconic aciduria type III, encodes two transcripts targeted primarily to mitochondria.</a> August 10  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20372962/'>Optic atrophy 3 as a protein of the mitochondrial outer membrane induces mitochondrial fragmentation.</a> September 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20627962/'>A model of Costeff Syndrome reveals metabolic and protective functions of mitochondrial OPA3.</a> August 25  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21349918/'>A clinically complex form of dominant optic atrophy (OPA8) maps on chromosome 16.</a> August 10  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23355087/'>3-Methylglutaconic aciduria--lessons from 50 genes and 977 patients.</a> July 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23658835/'>Downregulation of OPA3 is responsible for transforming growth factor-Î²-induced mitochondrial elongation and F-actin rearrangement in retinal pigment epithelial ARPE-19 cells.</a> December 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24136862/'>A novel heterozygous OPA3 mutation located in the mitochondrial target sequence results in altered steady-state levels and fragmented mitochondrial network.</a> June 4  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24749080/'>Two novel compound heterozygous mutations in OPA3 in two siblings with OPA3-related 3-methylglutaconic aciduria.</a> April 22  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25159689/'>Clinical and molecular genetic findings in autosomal dominant OPA3-related optic neuropathy.</a> August 28  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25201222/'>Costeff syndrome: clinical features and natural history.</a> September 22  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25205859/'>Mutation screening of mitochondrial DNA as well as OPA1 and OPA3 in a Chinese cohort with suspected hereditary optic atrophy.</a> January 7  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26400325/'>Identification of copy number variation in the gene for autosomal dominant optic atrophy, OPA1, in a Chinese pedigree.</a> August 9  2015<br></body></html>
